CD-160130

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCD-160130
Drug Alias NamePDE-4 inhibitor (BlackSwan Pharma)PDE-4 inhibitor (Curacyte Discovery)PDE-4 inhibitor (Curacyte Discovery)CD-160130
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitorsVoltage-gated potassium channel subunit Kv11.1 blockers
TargetsVoltage-gated potassium channel subunit Kv11.1Phosphodieterase 4
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCuracyte AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBlackSwan Pharma GmbHCuracyte AGThe Medicines Company
Active IndicationsN/A
Inactive IndicationsLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A